Oculus Research — Garner, North Carolina

Oculus Research is a clinical research site located in Garner, North Carolina, United States 27529.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Oculus Research has participated in 18 clinical trials with 3 currently active.

Therapeutic areas: Dry Eye Disease (DED), Ocular Hypertension, Open Angle Glaucoma.

Sponsors: Dompé Farmaceutici S.p.A, Alcon Research, Bausch & Lomb Incorporated.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Garner

Browse all research sites in North Carolina · View every site in Garner

• UNC Health Cancer Care Garner
• Rex Hematology Oncology Associates-Garner
• Novo Nordisk Investigational Site
• WakeMed Garner Hlthplx
• Pfizer Investigational Site
• Visus Therapeutics Investigative Site
• Sylentis Investigative Site
• RHOA of Garner
• United States, North Carolina
• Clinical Site 15
• UNC Rex Hematology Oncology Associates of Garner

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oculus Research?

Oculus Research has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oculus Research conducted?

Oculus Research has 18 clinical trials on record, with 3 currently active. Their work covers Dry Eye Disease (DED), Ocular Hypertension, Open Angle Glaucoma.

Is Oculus Research accredited by Crixeo Clinical Trials?

Oculus Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oculus Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.